113101-85-2

Upstream product

• 95602-92-9 3,5-di-tert-butyl-4-hydroxycinnamic acid 

Downstream Products

• 148794-22-3 1,1-dimethylethyl 2-<3-<3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl>-1-oxo-2-propenyl>hydrazinecarboxylate 
• 130116-24-4 (E)-2,6-bis(1,1-dimethylethyl)-4-{2-[5-(methylthio)-1,3,4-thiadiazol-2-yl]ethenyl}phenol 
• 148773-22-2 (E)-3-<3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl>-2-propenoic acid hydrazide 
• 130116-81-3 (E)-3-<3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl>-2-propenoic acid 2-<(methylthio)thioxomethyl>hydrazide 

Relevant academic research and scientific papers

Design of 5-(3,5-di-tert-butyl-4-hydroxyphenyl)-1,3,4-thiadiazoles, - 1,3,4-oxadiazoles, and -1,2,4-triazoles as orally-active, nonulcerogenic antiinflammatory agents

To discover dual inhibitors of 5-lipoxygenase (LO) and cyclooxygenase (CO) with improved pharmacokinetic properties, we have designed and synthesized series of 1,2,4-triazole, 1,3,4-oxadiazole, and 1,3,4-thiadiazole di-tert- butylphenol derivatives which